Appearance of Environment‐Linked Azole Resistance in the Aspergillus fumigatus Complex in New Zealand
Mycoses · 2025
DOI: 10.1111/myc.70104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mycoses, 2025. Verfasst von Arthur J Morris und 5 weiteren Autor:innen. Beteiligte Einrichtung: New Zealand Mycology Reference Laboratory, LabPlus, Auckland City Hospital, Auckland, New Zealand. Hauptthemen laut MEDLINE: Aspergillus fumigatus, Azoles, Drug Resistance, Fungal, Antifungal Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, UK Natural Environment Reasearch Council, Canadian Institute for Advanced Research.
Abstract (Originalsprache)
Background
Until 2020, azole resistance in Aspergillus fumigatus complex isolates in New Zealand was due to cyp51A hot spot mutations. This report details the appearance of environment‐linked tandem repeat (TR)‐related azole resistance genotypes since 2021.
Methods
Isolates were tested by broth micro‐dilution. Clinical Laboratory Standards Institute criteria were used to define wild type (WT) and non‐wild type (non‐WT) isolates, which were identified by ß‐tubulin gene sequencing and had their cyp51A genotype for azole resistance determined. Whole genome sequencing (WGS) was applied to two patient pairs of sequential WT and non‐WT isolates.
Results
From January 2021 to June 2024, 15 of 147 (10.2%) A. fumigatus complex isolates were resistant or non‐WT for one or more azole agents. Genotyping detected hot spot mutations in four and TR‐associated resistance in nine. No mutations were detected in two isolates. Four of the five TR 46 mutations were TR 46 /Y121F/T289A. Three of the four TR 34 mutations were different. WGS of the paired isolates showed that the non‐WT isolates were distinct. Azole‐containing fungicides are available for home use from garden centres. Patients with TR‐associated resistance did not have any obvious exposure to azole‐containing fungicides. There was no evidence for healthcare‐acquired transmission.
Conclusions
A. fumigatus sensu stricto isolates with TR‐mutations linked to environmental resistance are now present in New Zealand. Those at risk of invasive A. fumigatus infection should receive advice to avoid high‐risk exposures. Reintroducing monitoring of azole‐containing fungicides is recommended.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- New Zealand Mycology Reference Laboratory, LabPlus, Auckland City Hospital, Auckland, New Zealand.
- Respiratory Medicine and New Zealand Lung Transplant Service, Auckland City Hospital, Auckland, New Zealand.
- Department of Infectious Disease Epidemiology, Imperial School of Public Health, London, UK.
ORCID-Profile: Arthur J Morris, Matthew C Fisher
Förderung
- Wellcome Trust
- UK Natural Environment Reasearch Council
- Canadian Institute for Advanced Research
- UK MRC
Zitieren
APA
Morris, A. J., McKinney, W. P., Roberts, S. A., Sithamparanathan, S., Chaudhry, Z., & Fisher, M. C. (2025). Appearance of Environment‐Linked Azole Resistance in the Aspergillus fumigatus Complex in New Zealand. Mycoses. https://doi.org/10.1111/myc.70104
Vancouver
Morris AJ, McKinney WP, Roberts SA, Sithamparanathan S, Chaudhry Z, Fisher MC. Appearance of Environment‐Linked Azole Resistance in the Aspergillus fumigatus Complex in New Zealand. Mycoses. 2025. doi:10.1111/myc.70104
BibTeX
@article{Morris2025,
author = {Morris, Arthur J and McKinney, Wendy P and Roberts, Sally A and Sithamparanathan, Sasiharan and Chaudhry, Zain and Fisher, Matthew C},
title = {Appearance of Environment‐Linked Azole Resistance in the Aspergillus fumigatus Complex in New Zealand},
journal = {Mycoses},
year = {2025},
doi = {10.1111/myc.70104}
}
EUVIMED